Mutations of the MEN1 tumor suppressor gene in pituitary tumors

Cancer Research

Volumn 57, Issue 24, 1997, Pages 5446-5451

  Zhuang, Zhengping ^a   Ezzat, Shereen Z ^f   Vortmeyer, Alexander O ^a   Weil, Robert ^b   Oldfield, Edward H ^b   Park, Won Sang ^a   Pack, Svetlana ^a   Huang, Steve ^a   Agarwal, Sunita K ^c   Guru, Siradanahalli C ^d   Manickam, Pachiappan ^d   Debelenko, Larisa V ^a   Kester, Mary Beth ^c   Olufemi, Shodimu Emmanuel ^f   Heppner, Christina ^c   Crabtree, Judy S ^d   Burns, A Lee ^c   Spiegel, Allen M ^c   Marx, Stephen J ^c   Chandrasekharappa, Settara C ^d   Collins, Francis S ^d   Emmert Buck, Michael R ^a   Liotta, Lance A ^a   Asa, Sylvia L ^e   Lubensky, Irina A ^a   more..

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^d NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^e MOUNT SINAI HOSPITAL   (Canada)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; FEMALE; GENE DELETION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOPHYSIS ADENOMA; HYPOPHYSIS TUMOR; MALE; MULTIPLE ENDOCRINE NEOPLASIA; PATHOGENESIS; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ADENOMA; ADULT; AGED; CHILD, PRESCHOOL; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; MALE; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; MUTATION; PITUITARY NEOPLASMS;

EID: 15144342434     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Ezzat, S., and Melmed, S. Pituitary tumors in the elderly. In: J. E. Morley and S. G. Korenman (eds.), Endocrinology and Metabolism in the Elderly, pp. 58-69. Boston: Blackwell Scientific Publications, 1991.
2. Asa, S. L. The role of hypothalamic hormones in the pathogenesis of pituitary adenomas. Pathol. Res. Pract., 187: 581-583, 1991.
3. Asa, S. L., Kovacs, K., Stefaneanu, L., Horvath, E., Billestrup, N., Gonzalez-Manchon, C., and Vale, W. Pituitary adenomas in mice transgenic for growth hormone-releasing hormone. Endocrinology, 131: 2083-2089, 1992.
4. Alexander, J. M., Biller, B. M. K., Bikkal, H., Zervas, N. T., Arnold, A., and Klibanski, A. Clinically nonfunctioning pituitary tumors are monoclonal in origin. J. Clin. Invest., 86: 336-340, 1990.
5. Herman, V., Fagin, J., Gonsky, R., Kovacs, K., and Melmed, S. Clonal origin of pituitary adenomas. J. Clin. Endocrinol. Metab., 71: 1427-1433, 1990.
6. s and adenylate cyclase activity in human GH-secreting pituitary adenomas. Nature (Lond.), 330: 566-568, 1987.
7. Karga, H. J., Alexander, J. M., Hedley-Whyte, E. T., Klibanski, A., and Jameson, J. L. Ras mutations in human pituitary tumors. J. Clin. Endocrinol. Metab., 74: 914-919, 1992.
8. Pei, L., Melmed, S., Scheithauer, B., Kovacs, K., and Prager, D. H-ras mutations in human pituitary carcinoma metastases. J. Clin. Endocrinol. Metab., 78: 842-846, 1994.
9. Cai, W. Y., Alexander, J. M., Hedley-Whyte, E. T., Scheithauer, B. W., Jameson, J. L., Zervas, N. T., and Klibanski, A. Ras mutations in human prolactinomas and pituitary carcinomas. J. Clin. Endocrinol. Metab., 78: 89-93, 1994.
10. Alvaro, V., Lévy, L., Dubray, C., Roche, A., Peillon, F., Quérat, B., and Joubert, D. Invasive human pituitary tumors express a point-mutated α-protein kinase-C. J. Clin. Endocrinol. Metab., 77: 1125-1129, 1993.
11. Ezzat, S., Zheng, L., Smyth, H. S., and Asa, S. L. The c-erbB-2/neu proto-oncogene in human pituitary tumors. Clin. Endocrinol., in press, 1997.
12. Cryns, V. L., Alexander, J. M., Klibanski, A., and Arnold, A. The retinoblastoma gene in human pituitary tumors. J. Clin. Endocrinol. Metab., 77: 644-646, 1993.
13. Zhu, J., Leon, S. P., Beggs, A. H., Busque, L., Gilliland, D. G., and Black, P. M. Human pituitary adenomas show no loss of heterozygosity at the retinoblastoma gene locus. J. Clin. Endocrinol. Metab., 78: 922-927, 1994.
14. Sumi, T., Stefaneanu, L., Kovacs, K., Asa, S. L., and Rindi, G. Immunohistochemical study of p53 protein in human and animal pituitary tumors. Endocrinol. Pathol., 4: 95-99, 1993.
15. Boggild, M. D., Jenkinson, S., Pistorello, M., Boscaro, M., Scanarini, M., McTernan, P., Perrett, C. W., Thakker, R. V., and Clayton, R. N. Molecular genetic studies of sporadic pituitary tumors. J. Clin. Endocrinol. Metab., 78: 387-392, 1994.
16. Dong, Q., Debelenko, L. V., Chandrasekharappa, S. C., Emmert-Buck, M. R., Zhuang. Z., Guru, S. C., Manickam, P., Skarulis, M., Lubensky, I. A., Liotta, L. A., Collins, F. S., Marx, S. J., and Spiegel, A. M. Loss of heterozygosity at 11q13: analysis of pituitary tumors, lung carcinoids, lipomas, and other uncommon tumors in subjects with familial multiple endocrine neoplasia type 1. J. Clin. Endocrinol. Metab., 82: 1416-1420, 1997.
17. Chandrasekharappa, S. C., Guru, S. C., Manickam, P., Olufemi, S-E., Collins, F. S., Emmert-Buck, M. R., Debelenko, L. V., Zhuang, Z., Lubensky, I. A., Liotta, L. A., Crabtree, J. S., Wang, Y., Roe, B. A., Weisemann, J., Boguski, M. S., Agarwal, S. K., Kester, M. B., Kim, Y. S., Heppner, C., Dong, Q., Spiegel, A. M., Burns, A. L., and Marx, S. J. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science (Washington DC), 276: 404-407, 1997.
18. Agarwal, S., Kester, M. B., Debelenko, L. V., Heppner, C., Emmert-Buck, M. R., Skarulis, M., Doppman, J., Kim, Y., Lubensky, I. A., Zhuang, Z., Boguski, M. S., Weisemann, J., Green, J., Guru, S., Manickam, P., Olufemi, S-E., Liotta, L. A., Chandrasekharappa, S., Collins, F. S., Spiegel, A. M., Burns, A. L., and Marx, S. J. Germline mutations of the MEN1 gene in familial MEN1 and related states. Hum. Mol. Genet., 6: 1169-1175, 1997.
19. Guru, S., Olufemi, S-E., Manickam, P., Cummings, C., Gieser, L. M., Pike, B. L., Bittner, M. L., Jiang, Y., Chinault, A. S., Novack, N. J., Brozowska, A., Crabtree, J., Wang, Y., Roe, B., Weisemann, J., Boguski, M., Agarwal, S., Burns, A. L., Spiegel, A. M., Marx, S. J., Flejter, W. L., de Jong, P. J., Collins, F. S., and Chandrasekharappa, S. A 2.8 Mb clone contig of the multiple endocrine neoplasia type 1 (MEN 1) region at 11q13. Genomics, 42: 436-445, 1997.
20. Zhuang, Z., Vortmeyer, A. O., Pack, S., Huang, S., Pham, T., Wang, C, Park, W. S., Agarwal, S., Debelenko, L. V., Kester, M. B., Guru, S., Manickam, P., Olufemi, S-E., Yu, F., Heppner, C., Crabtree, J., Skarulis, M., Venzon, D. J., Emmert-Buck, M. R., Spiegel, A. M., Chandrasekharappa, S. C., Collins, F. S., Burns, A. L., Marx S. J., Jensen, R. T., Liotta, L. A., and Lubensky, I. A. Somatic mutations of the MEN1 tumor suppressor gene in sporadic gastrinomas and insulinomas. Cancer Res., 57; 4682-4686, 1997.
21. Emmert-Buck, M. R., Lubensky, I. A., Dong, Q., Manickam, P., Guru, S., Kester, M. B., Olufemi, S-E., Agarwal, S., Burns, A. L., Spiegel, A. M., Collins, F. S., Marx, S. J., Zhuang, Z., Liotta, L. A., Chandrasekharappa, S., and Debelenko, L. V. Localization of the multiple endocrine neoplasia type 1 (MEN 1) gene based on tumor LOH analysis. Cancer Res., 57: 1855-1858, 1997.
22. James, M. R., Richard, C. W., III, Schott, J-J., Yousry, C., Clark, K., Bell, J., Terwilliger, J. D., Hazan, J., Dubray, C., Vignal, A., Agrapart, M., Imai, T., Nakamura, Y., Polymeropoulos, M., Weissenbach, J., Cox, D. R., and Lathrop, G. M. A radiation hybrid map of 506 STS markers spanning human chromosome 11. Nat. Genet., 8: 70-76, 1994.
23. Manickam, P., Guru, S., Debelenko, L. V., Agarwal, S., Olufemi, S-E., Weisemann, J., Boguski, M., Crabtree, J., Roe, B., Wang, Y., Lubensky, I. A., Zhuang, Z., Kester, M. B., Bums, A. L., Spiegel, A. M., Marx, S. J., Liotta, L. A., Emmert-Buck, M. R., Collins, F. S., and Chandrasekharappa, S. Eighteen new polymorphic markers in the multiple endocrine neoplasia type 1 (MEN 1) region. Hum. Genet., 101: 102-108, 1997.
24. Knudson, A. G. Hereditary cancer, oncogenes, and antioncogenes. Cancer Res., 45: 1437-1443, 1985.
25. Sheffield, V. C., Beck, J. S., Kwitek, A. E., Sandstrom, D. W., and Stone, E. M. The sensitivity of single-strand conformation polymorphism analysis for the detection of single base substitutions. Genomics, 16: 325-332, 1993.
26. Herman, J. G., Latif, F., Weng, Y., Lerman, M. I., Zbar, B., Liu, S., Samid, R., Dimn, D. S., Gnarra, J. R., Linehan, W. M., and Baylin, S. B. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc. Natl. Acad. Sci. USA, 91: 9700-9704, 1994.
27. Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E., Burger, P. C., Baylin, S. B., and Sidransky, D. 5′ CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/MTS1 in human cancers. Nat Med., 1: 686-692, 1995.
28. Zimmering, M. B., Katsumata, N., Sato, Y., Brandi, M. L, Aurbach, G. D., Marx, S. J., and Friesen, H. G. Increased basic fibroblast growth factor in plasma from multiple endocrine neoplasia type 1: relation to pituitary tumor. J. Clin. Endocrinol. Metab., 76: 1182-1187, 1993.
29. Ezzat, S., Smyth, H. S., Ramyar, L., and Asa, S. L. Heterogeneous in vivo and in vitro expression of basic fibroblast growth factor by human pituitary adenomas. J. Clin. Endocrinol. Metab., 80: 878-884, 1995.
30. Abbass, S. A. A., Asa, S. L., and Ezzat, S. Altered expression of fibroblast growth factor receptors in human pituitary adenomas. J. Clin. Endocrinol. Metab., 82: 1160-1166, 1997.
31. Pei, L., Melmed, S., Scheithauer, B., Kovacs, K., Benedict, W. F., and Prager, D. Frequent loss of heterozygosity at the retinoblastoma susceptibility gene (RB) locus in aggressive pituitary tumors: evidence for a chromosome 13 tumor suppressor gene other than RB. Cancer Res., 55: 1613-1616, 1995.
32. Beaudet, A. L., and Tsui, L. A suggested nomenclature for designating mutations. Hum. Mutat., 2: 245-248, 1993.